SCOLR Pharma, Inc. (AMEX: DDD), a specialty pharmaceutical company, focuses on developing and liscensing Controlled Delivery Technology (CDT®). This technology platform contains multiple patented oral drug delivery technologies for prescription, OTC and nutritional compounds. Through alliances with pharmaceutical and natural products industry companies, SCOLR co-develops new products and adds value as well as protection to existing product franchises. For further information, visit the Company’s web site at www.scolr.com.
- 17 years ago
QualityStocks
SCOLR Pharma, Inc. (AMEX: DDD)
Tags Rodman & Renshaw
Related Post
-
Rail Vision Ltd. (NASDAQ: RVSN) Strengthens Commercial Momentum with Next Phase of Israel Railways Collaboration
Rail Vision, Israel Railways outline next stage of ongoing relationship. The ShuntingYard system is engineered…
-
QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Highlights Revenue Expansion Following $61 Million Veloce Acquisition
SEGG Media (NASDAQ: SEGG, LTRYW) provided an investor update outlining the diversified and expanding revenue streams…
-
QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in NetworkNewsAudio on AI Service Robotics Commercialization
Nightfood Holdings (OTCQB: NGTF) is featured in a NetworkNewsAudio Audio Press Release titled “AI Service…